-
Researchers at the University of Pittsburgh in Pennsylvania have found that patients who take prescription drugs along with herbal supplements have few adverse reactions. Results of their study were published in the March 22 issue of the Archives of Internal Medicine.
-
The current study investigated the effects of bromelain on mild acute knee pain of less than three months duration in otherwise healthy adults.
-
Concerns about the toxicity and side effects of pharmaceutical drugs have fueled interest in complementary approaches to managing osteoarthritis symptoms, with some dietary supplements also claiming to actually treat the underlying condition. Foremost among these are glucosamine sulfate and chondroitin sulfate. Although the two sometimes are taken together, this review will focus on the use of glucosamine sulfate alone.
-
-
An elderly woman presents with a chief complaint of constipation, with few symptoms of acute abdomen. Would you suspect appendicitis in this patient? You may find a misleadingly benign physical assessment in older patients, despite the presence of a potentially lethal illness, warns Karen Hayes, ARNP, PhD, assistant professor at the School of Nursing at Wichita (KS) State University.
-
In proposed rules published May 18, 2004, the Centers for Medicare & Medicaid Services (CMS) proposes to incorporate these provisions of the BBA into Conditions of Participation (COPs) applicable to hospitals and to extend these requirements to skilled nursing facilities (SNFs).
-
The following goals were developed for home health care, but may not apply to all areas of home health, says Maryanne L. Popovich, RN, MPH, executive director of the Joint Commission home care accreditation program.
-
Midcycle self-assessments, tracer methodology, and less emphasis on examination of policy books are signs that the new survey process implemented by the Joint Commission on the Accreditation of Healthcare Organizations is truly different from the survey process of the past.
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA).
-
Few new antibiotics are in the pipeline; Pharmacy groups establish compounding accreditation board; Be aware of possible drug mix-ups for obstetrical patients; Pancreatic extract makers to submit marketing applications; Concurrent oxandrolone, warfarin use may have adverse effect.
